Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer

NCT00089102 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Kidney Cancer

Interventions

DRUG: gemcitabine hydrochloride
DRUG: irinotecan hydrochloride

Sponsor

Medical University of South Carolina